Therapy-related AML: a slip of the lip can sink a ship

Leuk Res. 2014 Mar;38(3):418-20. doi: 10.1016/j.leukres.2013.12.023. Epub 2014 Jan 5.

Authors

Robert Peter Gale¹, John M Bennett², F Owen Hoffman³

Affiliations

¹ Section of Haematology, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK W12 OHS. Electronic address: robertpetergale@gmail.com.
² Department of Pathology and Laboratory Medicine and James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, United States.
³ Oak Ridge Center for Risk Analysis, 102 Donner Drive, Oak Ridge, TN 37830, United States.

PMID: 24439054
DOI: 10.1016/j.leukres.2013.12.023

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents / adverse effects
Dose-Response Relationship, Drug
Dose-Response Relationship, Radiation
Gamma Rays / adverse effects
Humans
Leukemia, Myeloid, Acute / diagnosis*
Leukemia, Myeloid, Acute / etiology
Likelihood Functions
Uncertainty

Substances

Antineoplastic Agents